Bio Rad Financials

Trends View

Profitability View

Liquidity View

Fundamentals View

Competition View

Bio Rad Stock Summary

Bio Rad competes with Nexalin Technology, Electromed, SurModics, STRATA Skin, and Aurora Spine. Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Bio Rad operates under Diagnostics Research classification in USA and is traded on New York Stock Exchange. It employs 8000 people.

Bio Rad Key Financial Ratios

Bio Rad Key Balance Sheet Accounts

Bio Rad Key Income Statement Accounts

Bio Rad Key Cash Accounts

Bio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bio Rad's current stock value. Our valuation model uses many indicators to compare Bio Rad value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Rad competition to find correlations between indicators driving Bio Rad's intrinsic value. More Info.Bio Rad Laboratories is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Bio Rad's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Rad's earnings, one of the primary drivers of an investment's value.

Bio Rad Market Pulse

Today, most investors in Bio Rad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bio Rad's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Bio Rad growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Bio Rad help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bio Rad Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bio Rad Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing Bio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bio Rad's daily price indicators and compare them against related drivers.

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.